scispace - formally typeset
Journal ArticleDOI

Quantitative structure–activity relationship analysis and virtual screening studies for identifying HDAC2 inhibitors from known HDAC bioactive chemical libraries

TLDR
This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.
Abstract
Histone deacetylases (HDAC) are emerging as promising targets in cancer, neuronal diseases and immune disorders. Computational modelling approaches have been widely applied for the virtual screening and rational design of novel HDAC inhibitors. In this study, different machine learning (ML) techniques were applied for the development of models that accurately discriminate HDAC2 inhibitors form non-inhibitors. The obtained models showed encouraging results, with the global accuracy in the external set ranging from 0.83 to 0.90. Various aspects related to the comparison of modelling techniques, applicability domain and descriptor interpretations were discussed. Finally, consensus predictions of these models were used for screening HDAC2 inhibitors from four chemical libraries whose bioactivities against HDAC1, HDAC3, HDAC6 and HDAC8 have been known. According to the results of virtual screening assays, structures of some hits with pair-isoform-selective activity (between HDAC2 and other HDACs) were revealed. This study illustrates the power of ML-based QSAR approaches for the screening and discovery of potent, isoform-selective HDACIs.

read more

Citations
More filters
Journal ArticleDOI

Small molecule HDAC inhibitors: Promising agents for breast cancer treatment.

TL;DR: In conclusion, HDACs have shown desirable effects on breast cancer, especially when they are used in combination with other anticancer agents, and more multicenter and randomized Phase III studies are expected to be conducted pushing promising new therapies closer to the market.
Journal ArticleDOI

Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity

TL;DR: Detailed investigation on the estimation of absorption, distribution, metabolism, excretion, and toxicity (ADMET) suggested that compounds 4g, 6c, and 6g, while showing potent HDAC2 inhibitory activity and cytotoxicity, also potentially displayed ADMET characteristics desirable to be expected as promising anticancer drug candidates.
Journal ArticleDOI

Evaluation of pyrrole-2,3-dicarboxylate derivatives: Synthesis, DFT analysis, molecular docking, virtual screening and in vitro anti-hepatic cancer study

TL;DR: Pyrrole-2,3-dicarboxylate derivatives synthesized in this study significantly inhibited the growth of HepG2 cells in a dose-dependent manner and may be proven to be novel therapeutic candidates to cure cancer.
Journal ArticleDOI

Conformal prediction of HDAC inhibitors.

TL;DR: This work introduces a novel approach for epigenetic quantitative structure–activity relationship (QSAR) modelling using conformal prediction and discusses the development of models for 11 sets of inhibitors of histone deacetylases, which are one of the major epigenetic target families that have been screened.
References
More filters
Journal ArticleDOI

Thailandepsins: bacterial products with potent histone deacetylase inhibitory activities and broad-spectrum antiproliferative activities.

TL;DR: Thailandepsins represent new naturally produced HDAC inhibitors that are promising for anticancer drug development and can be beneficial towards certain types of cell lines.
Journal ArticleDOI

Histone deacetylase 2 (HDAC2) regulates chromosome segregation and kinetochore function via H4K16 deacetylation during oocyte maturation in mouse.

TL;DR: Hdac2 is implicate as the major HDAC that regulates global histone acetylation during oocyte development and HDAC2 is largely responsible for the deacetylation of H4K16 during maturation, and the results provide additional support that histone deacetyation that occurs during oocytes maturation is critical for proper chromosome segregation.
Journal ArticleDOI

Towards selective inhibition of histone deacetylase isoforms: what has been achieved, where we are and what will be next.

TL;DR: This Minireview aims at surveying recent developments as well as the design, synthesis and biological characterization of isoform‐selective derivatives of HDAC inhibitors and their derivatives.
Related Papers (5)